|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Apr 29, 2022
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Accounts receivable, net | |||||||||||||
| Inventories | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Operating lease right-of-use assets | |||||||||||||
| Property and equipment, net | |||||||||||||
| Intangible assets, net | |||||||||||||
| Goodwill | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses | |||||||||||||
| Sales returns reserve | |||||||||||||
| Settlement liability | |||||||||||||
| Convertible notes | |||||||||||||
| Long-term debt, current portion | |||||||||||||
| Other current liabilities | |||||||||||||
| Deferred revenue, current portion | |||||||||||||
| Lease liability, current portion | |||||||||||||
| Total current liabilities | |||||||||||||
| Lease liability, noncurrent portion | |||||||||||||
| Long-term debt, noncurrent portion | |||||||||||||
| Total liabilities | |||||||||||||
| Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; zero shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | |||||||||||||
| Common stock; $0.0001 par value; 450,000,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; 20,762,389 and 20,726,965 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders' equity | |||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||
Loading...
